Oxford Science Enterprises plc
Insider
- 2025
- Sep 11, 2026
- 2
Other insiders active in the same sector
No other insider has filed at Oxford Science Enterprises plc's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Matthew Rabinowitz - $124.05M in NTRA purchases and sales in the last 12 months
- BAKER BROS. ADVISORS LP - $118.63M in KOD purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $117.62M in ARTV purchases and sales in the last 12 months
- SVF Pauling (Cayman) Ltd - $116.40M in RLAY purchases and sales in the last 12 months
- Bain Capital Life Sciences Investors, LLC - $115.00M in HTFL purchases and sales in the last 12 months
- Michael Simanovsky - $110.65M in SNDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Oxford Science Enterprises plc?
Oxford Science Enterprises plc is a corporate entity of Barinthus Biotherapeutics plc. (BRNS). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Oxford Science Enterprises plc submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Oxford Science Enterprises plc been buying or selling stock?
Recorded transactions: 1 open-market purchase ($640K) and 0 open-market sales across all tracked filings.